What's in Italian Sarcoma Group's pipeline?

Italian Sarcoma Group has 9 drugs in our index: 5 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Italian Sarcoma Group's portfolio?

Top competitors by shared drug class: Institute of Hematology & Blood Diseases Hospital, China, PETHEMA Foundation, Alberta Health services, Assistance Publique - Hôpitaux de Paris, Assistance Publique Hopitaux De Marseille.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/italian-sarcoma-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Italian Sarcoma Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Italian Sarcoma Group pipeline: 5 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 1 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
ETO	ETO	marketed	Topoisomerase II inhibitor	Topoisomerase II	Oncology
CYC	CYC	marketed	Alkylating agent	DNA	Oncology
IFO	IFO	marketed	Alkylating Agent	DNA	Oncology
ADM	ADM	marketed	Anthracycline chemotherapy agent	Topoisomerase II; DNA	Oncology
VIN	VIN	marketed	Vinca alkaloid; microtubule inhibitor	β-tubulin	Oncology
Intensified chemotherapy	Intensified chemotherapy	phase 3	Cytotoxic chemotherapy combination		Oncology

Therapeutic area mix

Oncology · 6

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Institute of Hematology & Blood Diseases Hospital, China · 2 shared drug classes
PETHEMA Foundation · 2 shared drug classes
Alberta Health services · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
AstraZeneca · 1 shared drug class
Asahi Kasei Pharma Corporation · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Italian Sarcoma Group:

Cite this brief

Drug Landscape (2026). Italian Sarcoma Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/italian-sarcoma-group. Accessed 2026-06-10.